Suppr超能文献

慢性阻塞性肺疾病(COPD)患者呼吸道药物依从性的相关因素

Correlates of adherence to respiratory drugs in COPD patients.

作者信息

Laforest Laurent, Denis Francois, Van Ganse Eric, Ritleng Cecile, Saussier Christel, Passante Nadine, Devouassoux Gilles, Chatté Gerard, Freymond Nathalie, Pacheco Yves

机构信息

Unité de Neuro-Pharmaco-Epidémiologie, CHU: University Hospital Lyon, Lyon, France.

出版信息

Prim Care Respir J. 2010 Jun;19(2):148-54. doi: 10.4104/pcrj.2010.00004.

Abstract

AIMS

To identify the correlates of accidental omissions and intentional interruptions of respiratory therapy in COPD.

METHODS

COPD patients (GOLD stages II-IV) were recruited by general practitioners or respiratory physicians. Patients reported in self-report questionnaires their adherence to respiratory drugs (over the past three months) and their perception of therapy.

RESULTS

179 patients were included (mean age 63 years, 24% females). 45% forgot their respiratory therapy, while 30% interrupted it in the absence of any perceived benefit. The risks of accidental omissions were significantly higher when patients complained about having too many medications to take on a daily basis (OR=2.35; 95%CI=1.13-4.89), and among current smokers (OR=2.14; 95%CI=1.07-4.29). Females were more likely to interrupt therapy intentionally (OR=2.40; 95%CI=1.04-5.53). Surprisingly, there was no significant relationship with the number of drugs actually taken by patients.

CONCLUSIONS

Adherence to respiratory drugs is inadequate in COPD patients. In order to improve adherence, patients' perception of the burden of therapy should not be overlooked.

摘要

目的

确定慢性阻塞性肺疾病(COPD)患者呼吸治疗意外遗漏和故意中断的相关因素。

方法

由全科医生或呼吸内科医生招募COPD患者(GOLD分级II-IV级)。患者通过自我报告问卷报告他们对呼吸药物的依从性(过去三个月)以及他们对治疗的看法。

结果

纳入179例患者(平均年龄63岁,24%为女性)。45%的患者忘记进行呼吸治疗,而30%的患者在未感觉到任何益处的情况下中断治疗。当患者抱怨每天要服用的药物太多时,意外遗漏的风险显著更高(比值比[OR]=2.35;95%置信区间[CI]=1.13-4.89),在当前吸烟者中也是如此(OR=2.14;95%CI=1.07-4.29)。女性更有可能故意中断治疗(OR=2.40;95%CI=1.04-5.53)。令人惊讶的是,这与患者实际服用的药物数量没有显著关系。

结论

COPD患者对呼吸药物的依从性不足。为了提高依从性,不应忽视患者对治疗负担的看法。

相似文献

1
Correlates of adherence to respiratory drugs in COPD patients.
Prim Care Respir J. 2010 Jun;19(2):148-54. doi: 10.4104/pcrj.2010.00004.
2
Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Respiration. 2011;82(4):328-34. doi: 10.1159/000324453. Epub 2011 Apr 1.
3
Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence.
COPD. 2015 Apr;12(2):151-64. doi: 10.3109/15412555.2014.922067. Epub 2014 Jun 24.
4
Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
Int J Chron Obstruct Pulmon Dis. 2017 Oct 6;12:2929-2942. doi: 10.2147/COPD.S136256. eCollection 2017.
5
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):479-488.e1. doi: 10.1016/j.japh.2019.04.017. Epub 2019 May 22.
6
Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).
Eur J Clin Pharmacol. 2012 Oct;68(10):1365-73. doi: 10.1007/s00228-012-1279-5. Epub 2012 Apr 5.
7
Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
COPD. 2012 Jun;9(3):251-8. doi: 10.3109/15412555.2011.650241. Epub 2012 Apr 12.
8
Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
Eur Respir J. 2011 Feb;37(2):264-72. doi: 10.1183/09031936.00051110. Epub 2010 Nov 29.
9
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD).
BMC Pulm Med. 2018 Oct 19;18(1):163. doi: 10.1186/s12890-018-0724-3.
10
COPD management in primary care: an observational, community pharmacy-based study.
Ann Pharmacother. 2010 Feb;44(2):257-66. doi: 10.1345/aph.1M481. Epub 2010 Jan 26.

引用本文的文献

1
The impact of patient characteristics and social drivers of health factors on oral oncolytic adherence.
J Manag Care Spec Pharm. 2025 Mar;31(3):306-320. doi: 10.18553/jmcp.2025.31.3.306.
2
Medication adherence halves COPD patients' hospitalization risk - evidence from Swiss health insurance data.
NPJ Prim Care Respir Med. 2024 Mar 7;34(1):1. doi: 10.1038/s41533-024-00361-2.
7
Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease.
Multidiscip Respir Med. 2020 May 5;15(1):654. doi: 10.4081/mrm.2020.654. eCollection 2020 Jan 28.
8
Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy.
Int J Chron Obstruct Pulmon Dis. 2019 Dec 16;14:2905-2915. doi: 10.2147/COPD.S222762. eCollection 2019.
9
Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study.
Int J Chron Obstruct Pulmon Dis. 2019 Aug 20;14:1839-1854. doi: 10.2147/COPD.S214061. eCollection 2019.
10
Status of and strategies for improving adherence to COPD treatment.
Int J Chron Obstruct Pulmon Dis. 2019 Jul 10;14:1503-1515. doi: 10.2147/COPD.S170848. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验